Articles with public access mandates - Joanne EdwardsLearn more
Not available anywhere: 5
Review
GRP78 up‐regulation is associated with androgen receptor status, Hsp70–Hsp90 client proteins and castrate‐resistant prostate cancer
SS Tan, I Ahmad, HL Bennett, L Singh, C Nixon, M Seywright, ...
The Journal of pathology 223 (1), 81-87, 2011
Mandates: Cancer Research UK
Review
Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor
L MacKenzie, P McCall, S Hatziieremia, J Catlow, C Adams, P McArdle, ...
Human pathology 43 (9), 1491-1500, 2012
Mandates: Cancer Research UK
Review
Evaluation of combined cytoplasmic AR in tumour cells expression and tumour CD3 T-cells infiltrate as a prognostic score for patients with prostate cancer: PS145
V Constâncio, M McAllister, S Patek, M Underwood, H Leung, J Edwards
Porto Biomedical Journal 2 (5), 181-182, 2017
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
Review
573P Multiparameter immunoprofiling reveals independent prognostic value of intraepithelial CD8 and intrastromal FoxP3 infiltrate in stage II/III colorectal cancer: Analysis of …
DN Church, A Frei, A McGuigan, R Sinha, A Harkin, TJ Iveson, ...
Annals of Oncology 34, S421-S422, 2023
Mandates: Cancer Research UK
Review
568P Single cell AI-based detection of DNA mismatch repair deficiency in 1,988 colorectal cancers reveals prognostic and predictive value in the SCOT trial
F Jabbar, M Nowak, AK Rodewald, L Gneo, T Tomasevic, A Harkin, ...
Annals of Oncology 34, S420, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK
Available somewhere: 105
Review
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion–resistant growth
Z Guo, X Yang, F Sun, R Jiang, DE Linn, H Chen, H Chen, X Kong, ...
Cancer research 69 (6), 2305-2313, 2009
Mandates: US National Institutes of Health
Review
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
C Sebastián, BMM Zwaans, DM Silberman, M Gymrek, A Goren, L Zhong, ...
Cell 151 (6), 1185-1199, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer
R Hu, C Lu, EA Mostaghel, S Yegnasubramanian, M Gurel, C Tannahill, ...
Cancer research 72 (14), 3457-3462, 2012
Mandates: US National Institutes of Health
Review
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15, 1-37, 2013
Mandates: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
Review
Mannose impairs tumour growth and enhances chemotherapy
PS Gonzalez, J O’Prey, S Cardaci, VJA Barthet, J Sakamaki, F Beaumatin, ...
Nature 563 (7733), 719-723, 2018
Mandates: Cancer Research UK, UK Medical Research Council, Worldwide Cancer Research, UK
Review
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study
E Kirmeier, LI Eriksson, H Lewald, MJ Fagerlund, A Hoeft, M Hollmann, ...
The Lancet Respiratory Medicine 7 (2), 129-140, 2019
Mandates: National Institute for Health Research, UK
Review
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...
The Lancet Oncology 22 (11), 1507-1517, 2021
Mandates: Cancer Research UK, Department of International Development, UK, UK Economic …
Review
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of …
C Watson, JS Long, C Orange, CL Tannahill, E Mallon, LM McGlynn, ...
The American journal of pathology 177 (5), 2205-2215, 2010
Mandates: Cancer Research UK
Review
MCL-1 is a prognostic indicator and drug target in breast cancer
KJ Campbell, S Dhayade, N Ferrari, AH Sims, E Johnson, SM Mason, ...
Cell death & disease 9 (2), 19, 2018
Mandates: Breast Cancer Now, UK, Cancer Research UK, Royal Society UK
Review
SRC family kinase activity is up-regulated in hormone-refractory prostate cancer
O Tatarov, TJ Mitchell, M Seywright, HY Leung, VG Brunton, J Edwards
Clinical Cancer Research 15 (10), 3540-3549, 2009
Mandates: Cancer Research UK
Review
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
P Rajan, IM Sudbery, MEM Villasevil, E Mui, J Fleming, M Davis, I Ahmad, ...
European urology 66 (1), 32-39, 2014
Mandates: Cancer Research UK, UK Medical Research Council
Review
Sphingosine 1-phosphate signalling in cancer
NJ Pyne, F Tonelli, KG Lim, JS Long, J Edwards, S Pyne
Biochemical Society Transactions 40 (1), 94-100, 2012
Mandates: Cancer Research UK
Review
Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient
T Mulholland, M McAllister, S Patek, D Flint, M Underwood, A Sim, ...
Scientific reports 8 (1), 14672, 2018
Mandates: Prostate Cancer UK
Review
Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer
I Ahmad, E Mui, L Galbraith, R Patel, EH Tan, M Salji, AG Rust, ...
Proceedings of the National Academy of Sciences 113 (29), 8290-8295, 2016
Mandates: Cancer Research UK, UK Medical Research Council
Review
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer
SRC McCracken, A Ramsay, R Heer, ME Mathers, BL Jenkins, J Edwards, ...
Oncogene 27 (21), 2978-2988, 2008
Mandates: Dunhill Medical Trust, UK
Publication and funding information is determined automatically by a computer program